102 related articles for article (PubMed ID: 12811640)
1. GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis.
Kalkman HO; Loetscher E
J Neural Transm (Vienna); 2003 Jul; 110(7):803-12. PubMed ID: 12811640
[TBL] [Abstract][Full Text] [Related]
2. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
Woo TU; Walsh JP; Benes FM
Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
[TBL] [Abstract][Full Text] [Related]
3. Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats.
Oda Y; Fujita Y; Oishi K; Nakata Y; Takase M; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
Psychopharmacology (Berl); 2017 Oct; 234(20):3027-3036. PubMed ID: 28744562
[TBL] [Abstract][Full Text] [Related]
4. Reduced dendrite growth and altered glutamic acid decarboxylase (GAD) 65- and 67-kDa isoform protein expression from mouse cortical GABAergic neurons following excitotoxic injury in vitro.
Monnerie H; Le Roux PD
Exp Neurol; 2007 Jun; 205(2):367-82. PubMed ID: 17433299
[TBL] [Abstract][Full Text] [Related]
5. Glutamate alteration of glutamic acid decarboxylase (GAD) in GABAergic neurons: the role of cysteine proteases.
Monnerie H; Le Roux PD
Exp Neurol; 2008 Sep; 213(1):145-53. PubMed ID: 18599042
[TBL] [Abstract][Full Text] [Related]
6. Role of the NR2A/2B subunits of the N-methyl-D-aspartate receptor in glutamate-induced glutamic acid decarboxylase alteration in cortical GABAergic neurons in vitro.
Monnerie H; Hsu FC; Coulter DA; Le Roux PD
Neuroscience; 2010 Dec; 171(4):1075-90. PubMed ID: 20923697
[TBL] [Abstract][Full Text] [Related]
7. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.
Fatemi SH; Stary JM; Earle JA; Araghi-Niknam M; Eagan E
Schizophr Res; 2005 Jan; 72(2-3):109-22. PubMed ID: 15560956
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain.
Qin ZH; Zhang SP; Weiss B
Brain Res Mol Brain Res; 1994 Feb; 21(3-4):293-302. PubMed ID: 8170353
[TBL] [Abstract][Full Text] [Related]
9. Metabolic distinction between vesicular and cytosolic GABA in cultured GABAergic neurons using 13C magnetic resonance spectroscopy.
Waagepetersen HS; Sonnewald U; Gegelashvili G; Larsson OM; Schousboe A
J Neurosci Res; 2001 Feb; 63(4):347-55. PubMed ID: 11170185
[TBL] [Abstract][Full Text] [Related]
10. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
11. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.
Heckers S; Stone D; Walsh J; Shick J; Koul P; Benes FM
Arch Gen Psychiatry; 2002 Jun; 59(6):521-9. PubMed ID: 12044194
[TBL] [Abstract][Full Text] [Related]
12. Development of human visual cortex: a balance between excitatory and inhibitory plasticity mechanisms.
Murphy KM; Beston BR; Boley PM; Jones DG
Dev Psychobiol; 2005 Apr; 46(3):209-21. PubMed ID: 15772972
[TBL] [Abstract][Full Text] [Related]
13. Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression.
Karolewicz B; Maciag D; O'Dwyer G; Stockmeier CA; Feyissa AM; Rajkowska G
Int J Neuropsychopharmacol; 2010 May; 13(4):411-20. PubMed ID: 20236554
[TBL] [Abstract][Full Text] [Related]
14. Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus.
Freichel C; Potschka H; Ebert U; Brandt C; Löscher W
Neuroscience; 2006 Sep; 141(4):2177-94. PubMed ID: 16797850
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of extensive GABA synthesis in the small population of GAD positive neurons in cerebellar cultures by the use of pharmacological tools.
Sonnewald U; Kortner TM; Qu H; Olstad E; Suñol C; Bak LK; Schousboe A; Waagepetersen HS
Neurochem Int; 2006; 48(6-7):572-8. PubMed ID: 16516347
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glutamate/glutamine cycle in vivo results in decreased benzodiazepine binding and differentially regulated GABAergic subunit expression in the rat brain.
Cremer CM; Bidmon HJ; Görg B; Palomero-Gallagher N; Escobar JL; Speckmann EJ; Zilles K
Epilepsia; 2010 Aug; 51(8):1446-55. PubMed ID: 20384720
[TBL] [Abstract][Full Text] [Related]
17. GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus.
Wierońska JM; Brański P; Siwek A; Dybala M; Nowak G; Pilc A
Brain Res; 2010 Jun; 1334():12-24. PubMed ID: 20353761
[TBL] [Abstract][Full Text] [Related]
18. The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention.
Pehrson AL; Bondi CO; Totah NK; Moghaddam B
Psychopharmacology (Berl); 2013 Jan; 225(1):31-9. PubMed ID: 22797703
[TBL] [Abstract][Full Text] [Related]
19. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
Lavoute C; Weiss M; Rostain JC
Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
[TBL] [Abstract][Full Text] [Related]
20. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
